PGA5 is related to the prolongation of survival time of cancer patients in kidney renal clear cell carcinoma and kidney renal papillary cell carcinoma, while it is related to the shortening of survival time of cancer patients in lung squamous cell carcinoma, prostate adenocarcinoma, and uterine corpus endometrial carcinoma. This evidence concerns the gene PGA5 and prostate adenocarcinoma.